Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.1% in the morning session after Piper Sandler initiated coverage on the stock with a Neutral rating and a $15.00 price target. While the ...
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6% in the morning session after BofA Securities maintained its "Buy" rating on the stock, even while lowering its price target. The firm ...
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded ...
10x Genomics has faced significant revenue declines and operational challenges, with Q3 revenue missing expectations and instrument sales dropping 46% year-over-year. Despite the setbacks, consumables ...
Hosted on MSN
Why 10x Genomics (TXG) Stock Is Trading Up Today
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 1.5% in the afternoon session after it announced a strategic partnership with SPT Labtech, a laboratory automation company, to provide ...
I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption, ...
10x Genomics TXG shares ended the last trading session 11.1% higher at $13.14. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback